Press release

Covetrus Releases Signature Enhancements to its Industry-Leading AVImark Practice Management Software for Veterinary Practices

Sponsored by Businesswire

(NASDAQ: CVET), a global leader in animal-health technology and
services, announced today the release of signature product enhancements
to its AVImark practice management software, including new functionality
that streamlines common veterinary practice administrative tasks and
drives greater coordination between the medical record and Covetrus’
prescription management technology.

These AVImark enhancements represent one of the many planned innovation
investments across our technology assets that are scheduled to go-live
in 2019 as Covetrus looks to improve workflow, create time savings for
caregivers and staff, simplify practice operations and enhance clinical
and financial health for our growing customer base.

“The growing complexity of managing a small business in an evolving
veterinary landscape is increasing the burden on the veterinarian and
their team of professionals,” said Chris Dollar, senior vice president
and president, Global Software Services. “Our increased investment in
practice management software for 2019 demonstrates our commitment to our
customers as we look to not only deliver a better user-experience but to
also launch next-generation functionality and workflow improvements to
help these practices deliver quality patient care.”

Some of the new AVImark enhancements and features include:

Medical record quick copy forward: This allows practitioners
to quickly copy and add new notes on a patient’s condition,
significantly reducing the amount of time spent on medical record
note taking.
Prescription management coordination: Prescriptions filled by
the Covetrus prescription management technology flow directly to the
patient’s medical record, bringing a complete view of a patient’s
medication history inside AVImark. By pairing AVImark with the
Covetrus prescription management technology, practices can bring
compliance to a whole new level.
Quick indicators: New indicators help with quick
determinations of statuses to simplify AVImark customers’ work.
Wellness plan indicators allow staff members to see patients on
wellness plans. Estimates that have been approved now have a clear
locked indicator from the main screen to ensure staff members know
which estimate has currently been accepted by the pet owner.
Practitioners can save time by getting a list of their open medical
records through an information search.

These AVImark upgrades come on the heels of new integrations and
innovations launched by other Covetrus practice management solutions in
the second quarter of 2019, including Covetrus prescription and
inventory management integration for eVetPractice, multiple performance
improvements that enhance speed to launch for ImproMed software
customers, and significant new features for RxWorks internationally.

Covetrus Global Software Services will showcase these and other future
innovations at VetSummit 2019: October 9-11 in Indianapolis, Indiana.

About Covetrus

Covetrus is a global animal-health technology and services company
dedicated to empowering veterinary practice partners to drive improved
health and financial outcomes. We’re bringing together products,
services, and technology into a single platform that connects our
customers to the solutions and insights they need to work best. Our
passion for the well-being of animals and those who care for them drives
us to advance the world of veterinary medicine. Covetrus is
headquartered in Portland, Maine, with more than 5,000 employees,
serving over 100,000 customers around the globe. For more information
about Covetrus visit

Forward-Looking Statements

This press release contains certain statements that are forward-looking
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, and that involve risks and uncertainties, including statements
about our future financial and operating results, plans, objectives,
expenses, expectations, intentions, trends in our business, our
liquidity, product development and improvements, and other matters. We
may, in some cases use terms such as “predicts,” “believes,”
“potential,” “continue,” “anticipates,” “estimates,” “expects,” “plans,”
“intends,” “may,” “could,” “might,” “likely,” “will,” “should” or other
words that convey uncertainty of the future events or outcomes to
identify these forward-looking statements. Such statements are subject
to numerous risks and uncertainties, including but not limited to, risks
associated with the ability to successfully integrate operations and
employees; the ability to realize anticipated benefits and synergies of
the transaction that created Covetrus; the potential impact of the
consummation of the transaction on relationships, including with
employees, customers and competitors; the ability to retain key
personnel; the ability to achieve performance targets; changes in
financial markets, interest rates and foreign currency exchange rates,
and those additional risks and factors discussed in our Annual Report on
Form 10-K filed on March 29, 2019 and Quarterly Report on Form 10-Q
filed for the quarter ended March 31, 2019, including those discussed
under the heading “Risk Factors.” Our forward-looking statements are
based on current beliefs and expectations of our management team and,
except as required by law, we undertake no obligations to make any
revisions to the forward-looking statements contained in this release or
to update them to reflect events or circumstances occurring after the
date of this release, whether as a result of new information, future
developments or otherwise. Investors are cautioned not to place undue
reliance on these forward-looking statements.